4 Keys To Allo In 2024 With Poseida Therapeutics' Kristin Yarema, Ph.D.
Source: Cell & Gene
Kristin Yarema, Ph.D., CEO, Poseida Therapeutics sits down with Cell & Gene: The Podcast Host Erin Harris to discuss four of the biggest challenges the CGT sector faces when it comes to the development of off-the-shelf therapies. Kristin shares how 2024 might see some real progress in allogeneic therapies.
This website uses cookies to ensure you get the best experience on our website. Learn more